ISSN (Online): 2666-9587

VOLUME: 5, 2025

ISSN (Online): 2666-9587

VOLUME: 5, 2025



AIMS AND SCOPE

The Open COVID Journal is an international, peer-reviewed, open-access journal dedicated to publishing innovative and impactful research across all aspects of coronaviruses and COVID-19. In light of the rapid and ongoing scientific advances, the journal has broadened its scope to address emerging areas of significance in coronavirus biology, disease pathogenesis, host response, and public health impact.


We welcome a wide range of contributions, including original research articles, letters, reviews/mini-reviews, case studies, clinical trial reports, and guest-edited thematic issues. The journal is committed to the timely dissemination of high-quality findings that advance our understanding and management of coronavirus-associated diseases.


Scope of the Journal Includes:


  • Coronavirus Biology and Evolution

    Origins, genomic diversity, evolution, viral entry mechanisms, replication strategies, and zoonotic spillover dynamics of coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2, and related viruses).


  • Host-Virus Interactions

    Innate and adaptive immune responses, cytokine signaling, immune evasion strategies, virus-induced inflammation, and host genetic susceptibility factors.


  • Pathogenesis and Disease Mechanisms

    Multisystem involvement in acute infection, immune dysregulation, vascular and neurological complications, and mechanisms underlying severe disease and mortality.


  • Post-Acute Sequelae (Long COVID)

    Clinical characterization, molecular and immunological underpinnings, impact on quality of life, and strategies for diagnosis and management of long COVID.


  • Therapeutics and Vaccine Development

    Antiviral agents, monoclonal antibodies, immunomodulatory drugs, vaccine design and efficacy, real-world effectiveness, and strategies for next-generation vaccines.


  • Diagnostics and Biomarkers

    Development and validation of molecular, antigen, and serological assays; identification of prognostic and predictive biomarkers for disease progression and recovery.


  • Public Health, Epidemiology, and Policy

    Surveillance, transmission modeling, outbreak response, vaccine coverage, health disparities, pandemic preparedness, and policy responses.


  • Clinical Trials and Translational Studies

    Interventional studies evaluating therapeutic efficacy, vaccine trials, observational cohorts, and translational research bridging bench to bedside.


  • Global Health and Socioeconomic Impacts

    Health system responses, mental health, education, economic recovery, and lessons learned for future pandemic resilience.


All published content is made freely and globally accessible to support open science and foster collaborative solutions to ongoing and future coronavirus threats.


The Open COVID Journal is an international, peer-reviewed, open-access journal covering all aspects of coronaviruses published continuously by Bentham Open.


parallax-img
tocovidj-Ning-s-be.gif

ABOUT THE EDITOR

  • Shunbin Ning

  • Scopus-logo
  • Affiliation:

    Department of Internal Medicine
    Quillen College of Medicine
    East Tennessee State University
    Johnson City, TN
    USA

    Affiliation:

    Department of Internal Medicine
    Quillen College of Medicine
    East Tennessee State University
    Johnson City, TN
    USA

    Editor's Choice